http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2201230-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68127d0e2b28febb82d25d52710acf24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2001-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d4e292554dc0426a1f4e549f62f694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ecbb8689f081602f58b0459855164a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2d65e0f38aa344060982e2ff98d7f6 |
| publicationDate | 2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2201230-C1 |
| titleOfInvention | Medicinal agent "flusol" eliciting antifungal effect |
| abstract | FIELD: medicine, dermatology. SUBSTANCE: agent is made as capsules and comprises fluconazole as active substance and lactose, maize starch, colloidal silicon oxide, magnesium stearate and sodium lauryl sulfate as accessory substances taken in the definite ratio of components. Medicinal agent named as "FLUSOL" is fluconazolebase preparation of domestic industry. Agent provides treatment of sickness of wide spectrum and does not cause pathological alternations in visceral organs in oral intake. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 4 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005002553-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-008585-B1 |
| priorityDate | 2001-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.